The second tier of market taxonomy distinguishes implant types, each with distinct engineering and clinical implications. Endosteal implants dominate the landscape, representing roughly 70 % of units shipped; they are further divided into screw‑type, blade‑type, and cylinder‑type sub‑variants. Screw‑type implants, the most widely adopted, offer superior primary stability and are compatible with digital planning platforms, thereby driving bulk of the volume. Blade‑type and cylinder‑type designs, although less common, address narrow ridge situations where conventional screw‑type placement is contraindicated. Subperiosteal implants constitute about 15 % of the market and are custom‑fabricated frameworks that rest on the alveolar bone, primarily serving patients with severe bone loss who cannot undergo extensive grafting. The emerging zygomatic implant niche, accounting for roughly 10 % of sales, provides an alternative anchorage in the zygomatic bone for severely atrophic maxillae, leveraging specialized surgical protocols. Each type’s market share reflects its clinical applicability, reimbursement environment, and adoption of adjunctive technologies, delivering a comprehensive view of the market taxonomy beyond application‑level analysis.